BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?

Vaccination against an airborne pathogen is very effective if it induces also the development of mucosal antibodies that can protect against infection. The mRNA‐based vaccine‐encoding SARS‐CoV‐2 full‐length spike protein (BNT162b2, Pfizer/BioNTech) protects also against infection despite being admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwich, Abbass, Pozzi, Chiara, Fornasa, Giulia, Lizier, Michela, Azzolini, Elena, Spadoni, Ilaria, Carli, Francesco, Voza, Antonio, Desai, Antonio, Ferrero, Carlo, Germagnoli, Luca, Mantovani, Alberto, Rescigno, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081904/
https://www.ncbi.nlm.nih.gov/pubmed/35393790
http://dx.doi.org/10.15252/emmm.202115326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081904/
https://www.ncbi.nlm.nih.gov/pubmed/35393790
http://dx.doi.org/10.15252/emmm.202115326

Ejemplares similares